Cite
HARVARD Citation
Paliouras, A. et al. (2020). Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition. EMBO molecular medicine. 12 (7), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Paliouras, A. et al. (2020). Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition. EMBO molecular medicine. 12 (7), p. n/a. [Online].